Navigation Links
Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results
Date:5/8/2009

million, or $0.76 per share, for the nine months ended March 31, 2008.

Cash, cash equivalents and investments were $28.8 million at March 31, 2009. The cash and total investments balance included cash, cash equivalents and short-term investments of $21.6 million and long-term auction-rate securities carried at an estimated value of $7.2 million and classified as long-term investments. Total liabilities, excluding deferred revenue of $14.7 million and a warrant liability of $0.2 million, were $6.4 million at March 31, 2009.

"During the third quarter of fiscal 2009, we wound-down most of our operations and significantly reduced expenses. We also initiated a process to identify and evaluate alternatives for the Company's future. Our board's stated mandate in looking at these strategic alternatives is to maximize the value of our cash and other assets for the benefit of all our shareholders, and to proceed expeditiously in the process," stated William Fletcher, acting Chief Executive Officer.

Assuming accrued costs associated with the Viprinex program are fully paid off by June 30, 2009 as currently estimated, the Company expects to end its fiscal year with approximately $23 million in cash, short-term and long-term investments.

-Tables to follow -

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions. The company recently terminated development of its most advanced product candidate, Viprinex(TM) (ancrod), which was studied in Phase 3 clinical trials as a potential new drug to treat acute ischemic stroke. NTI has more recently chosen not to extend its early-stage research programs for Huntington's and Alzheimer's diseases. NTI has rights to receive payments from an approved drug for Alzheimer's disease and an invest
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
2. Neurobiological Technologies Reports Second Quarter Financial Results
3. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
4. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
5. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
6. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
7. Neurobiological Technologies Reports Going Concern Qualification
8. Steven H. Kane Appointed as President and Chief Executive Officer of Patient Safety Technologies, Inc.
9. Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009
10. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
11. Greenway Medical Technologies PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... As Americans celebrate the Fourth of July outdoors this weekend, local physicians ... July is UV Safety Month, and physicians at American Family Care and AFC Doctors ... Experts say most skin cancers can be found early with regular skin exams. Physicians ...
(Date:7/2/2015)... ... 02, 2015 , ... The ZAC Foundation, a national leader in water safety ... on how to stay water safe with the help of a young polar bear ... ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, who is afraid of ...
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ... of Dr. Divakar R. Krishnareddy, M.D., to the orthopedic and spine surgery team ... disc herniations, sprains, strains, bursitis, and tendonitis. Along with the spine and spine ...
(Date:7/2/2015)... NY (PRWEB) , ... July 02, 2015 , ... ... for Carpal Tunnel treatment and wrist pain treatment. Dr. Lev Kalika, founder of ... – and a leading international authority on the conservative treatment of back, hip, ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman ... a new release of their flagship product, 3D Tooth Atlas, version 7.6. This ... section and new tutorial videos. This latest release of the 3D Tooth Atlas ...
Breaking Medicine News(10 mins):Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2
... National Institutes of Health has awarded a four-year, $1.4 million ... recent discovery: After ischemic stroke the type caused by ... a normal protein that plays a positive role in ... "We knew thrombin leaked out during hemorrhagic strokes ...
... HealthDay Reporter , TUESDAY, Nov. 22 (HealthDay News) -- ... harbor almost as much danger as too much salt, researchers report. ... than 6,000 or 7,000 milligrams of sodium per day, said Dr. ... issue of the Journal of the American Medical Association . ...
... News) -- ,A new study says that regular consumption of ... levels of bisphenol A (BPA), which has been associated with ... added that the increase may be temporary and more research ... the lining of metal food and beverage cans, in polycarbonate ...
... of you inside like there,s another half of you, ... the real me, the logic part of me, and it,s ... study participant with anorexia nervosa. (Garrison, NY) People ... "authentic," self whether their illness is separate from or ...
... in German . As the "recycling plant" ... it is inhibited, the cell chokes on its own waste. ... the proteasome for their uncontrolled growth. Biochemists at the Technische ... a new class of drugs that attacks the proteasome in ...
... -- Although men have higher cancer mortality rates than ... for cancer, according to a study conducted by researchers ... at Sanoa Consulting LLC, Muscle Shoals, Ala., and the ... which was funded by the National Institute of Dental ...
Cached Medicine News:Health News:How Much Salt Is Best for the Heart? 2Health News:How Much Salt Is Best for the Heart? 3Health News:BPA Levels Spike After Eating Canned Soup: Study 2Health News:Anorexia nervosa study finds inner conflicts over the 'real' self that have treatment implications 2Health News:New class of drugs for the reversible inhibition of proteasomes 2Health News:New class of drugs for the reversible inhibition of proteasomes 3Health News:Moffitt Cancer Center researchers find men less willing to be screened for cancer 2
(Date:7/2/2015)... BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading ... tissue hypothermic storage and cryopreservation freeze ... management app for smart shippers ("BioLife" or ... has included BioLife in its annual list of the 100 ... for 2015. Now in its 24th ...
(Date:7/2/2015)... July 2, 2015   Wilson Therapeutics AB , ... Hans Schikan to its board of directors. The appointment ... Meeting on June 30. "We are delighted ... Jonas Hansson , CEO of Wilson Therapeutics. "Hans ... we look forward to his contributions to the Company." ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Inaugural Healthcare Conference taking place in New ... Le Parker Meridien Hotel. James ... of the Company,s business during his live presentation and ...
Breaking Medicine Technology:BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: ... in China, today announced financial results for the quarter ended June ... Highlights Revenue increased 18% to $19.6 ... Cashflow from operations rose 10% to $3.6 million from $3.3 million ...
... N.J., Aug. 11, 2011 Pacira Pharmaceuticals, Inc. (Nasdaq: ... today announced financial results for the second quarter ended ... of its pre-commercial and launch strategies for EXPAREL™, and ... continued to aggressively execute our launch strategy for EXPAREL ...
Cached Medicine Technology:China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 2China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 3China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 4China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 5China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 6China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 7China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 8China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 9China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results 10Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 2Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 3Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 4Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 5Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 6Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 7Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 8Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 9Pacira Pharmaceuticals, Inc. Reports Second Quarter 2011 Financial Results 10
A three lamp light source maximizes use by allowing two surgeons to work simultaneously from it, while the third lamp is reserved for backup....
Cold light source single outlet....
Cold light source dual outlet....
The 9100 is a truly affordable 100 Watt xenon light source providing accurate color and brightness. This xenon light source is ideal for surgery centers, evaluations or general office use....
Medicine Products: